β2-agonists -: Short-acting β2-agonists

被引：0
|
作者：
机构：
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 1999年 / 161卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S28 / S31
页数：4
相关论文
共 50 条
  • [41] Regular use of corticosteroids and low use of short-acting β2-agonists can reduce asthma hospitalization
    Senthilselvan, A
    Lawson, JA
    Rennie, DC
    Dosman, JA
    CHEST, 2005, 127 (04) : 1242 - 1251
  • [42] Gas exchange response to short-acting β2-agonists in chronic obstructive pulmonary disease severe exacerbations
    Polverino, Eva
    Gomez, Federico P.
    Manrique, Hernan
    Soler, Nestor
    Roca, Josep
    Barbera, Joan Albert
    Rodriguez-Roisin, Roberto
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (04) : 350 - 355
  • [43] Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting β2-agonists
    Appleton, Sarah L.
    Ruffin, Richard E.
    Wilson, David H.
    Taylor, Anne W.
    Adams, Robert J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 124 - 130
  • [44] Detection of reasons for excessive use of short-acting β2-agonists (SABA) therapy in asthma: a descriptive study
    Visser, Claire D.
    Ozdemir, Ayse
    Faay, Maaike R. A.
    Guchelaar, Henk Jan
    Teichert, Martina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 798 - 798
  • [45] Overestimation of asthma control and misperception of short-acting β2-agonists (SABA) use among physicians in Poland
    Gawlik, Radoslaw
    Bochenek, GraZyna
    Brzostek, Dorota
    Barg, Wojciech
    Brozek, Grzegorz
    Dabrowiecki, Piotr
    Dabrowski, Andrzej
    Dobek, Rafal
    Kucharczyk, Aleksandra
    Kupczyk, Maciej
    Kuprys-Lipinska, Izabela
    Mastalerz-Migas, Agnieszka
    Kowalski, Marek L.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [46] Safety Trials of Long-Acting β2-Agonists
    Weinberger, Miles
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1481 - 1482
  • [47] Safety of long acting β2-agonists in the management of asthma
    Gillissen, A.
    Berdel, D.
    Buhl, R.
    Criee, C. -P.
    Kardos, P.
    Magnussen, H.
    Rabe, K. F.
    Rolke, M.
    Vogelmeier, C.
    Worth, H.
    Virchow, J. C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (1-2) : 33 - 39
  • [48] Benefits of long-acting β2-agonists -: Reply
    Gibson, Peter G.
    Ducharme, Francine M.
    Cates, Christopher Joseph
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 726 - 726
  • [49] Safety of long-acting β2-agonists in asthma
    Rishton, Louise
    LANCET RESPIRATORY MEDICINE, 2016, 4 (11): : 860 - 860
  • [50] Controversies regarding long-acting β2-agonists
    Khianey, Reena
    Oppenheimer, John
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (04) : 345 - 354
12345